Molecular mobility and physical stability of amorphous irbesartan

Scientia Pharmaceutica

Volumn 77, Issue 3, 2009, Pages 695-709

  Chawla, Garima ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Amorphous form; DSC; Enthalpy relaxation; Irbesartan; Molecular mobility; Stability

Indexed keywords

IRBESARTAN;

ARTICLE; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; GLASS TRANSITION TEMPERATURE; LOW TEMPERATURE; MOISTURE; PHYSICAL CHEMISTRY; TEMPERATURE SENSITIVITY; WETTABILITY;

EID: 70349272483     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0806-09     Document Type: Article

References (22)

1. Hancock BC, Dalton CR, Pikal MJ, Shamblin SL. A pragmatic tool of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials. Pharm Res. 1998: 15: 762-767. doi:10.1023/A: 1011931305755
2. Hancock BC. Disordered drug delivery: destiny, dynamics and the Deborah number. J Pharm Pharmacol. 2002; 54: 737-746. doi:10.1211/0022357021778989
3. Gunawan L, Johari GP, Shankar RM. Structural relaxation of acetaminophen glass. Pharm Res. 2006; 23: 967-979. doi:10.1007/s11095-006-9898-0
4. Shamblin SL, Hancock BC, Dupuis Y, Pikal MJ. Interpretation of relaxation time constants for amorphous pharmaceutical systems. J Pharm Sci. 2000; 89: 417-427. doi:10.1002/(SICI)1520-6017(200003)89:3〈417::AID-JPS12〉3.0. CO;2-V (Pubitemid 30152441)
5. Andronis V, Yoshioka M, Zografi G. Effect of absorbed water on crystallization of of indomethacin from the amorphous state. J Pharm Sci. 1997; 86: 346-351. doi:10.1021/js9602711 (Pubitemid 27113770)
6. 1H NMR relaxation times. J Pharm Sci. 2000; 89: 408-416. doi:10.1002/(SICI)1520-6017(200003)89:3〈408::AID- JPS11〉3.0.CO;2-#
7. Fukuoka E, Matika M, Yamamura S. Glassy state of pharmaceuticals. III. Thermal properties and stability of glassy pharmaceuticals and their binary glassy systems. Chem Pharm Bull. 1989; 37: 1047-1050.
8. Yoshioka M, Hancock B, Zografi G. Crystallization of indomethacin from the amorphous stet below and above its glass transition temperature. J Pharm Sci. 1994; 83: 1700-1705. doi:10.1002/jps.2600831211 (Pubitemid 24144434)
9. Oksanen C, Zografi G. Molecular mobility in mixtures of absorbed water and solid poly(vinylpyrolidone). Pharm Res. 1993; 10: 791-799. doi:10.1023/A:1018988506336 (Pubitemid 23167558)
10. Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm. 1990; 62: 87-95. doi:10.1016/0378-5173(90)90221-O (Pubitemid 20261777)
11. Chawla G, Bansal AK. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Eur J Pharm Sci. 2007; 32: 45-57. doi:10.1016/j.ejps.2007.05.111 (Pubitemid 47411498)
12. Law B, Krill SL, Schmitt EA, Fort JJ, Qiu Y, Wang W, Porter WR. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci. 2001; 90: 1015-1025. doi:10.1002/jps.1054
13. Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci. 2002; 91: 1863-1872. doi:10.1002/jps.10169 (Pubitemid 34810531)
14. Ediger MD, Angell CA, Nagel SR. Supercooled liquids and glasses. J Phys Chem. 1996; 100: 13200-13212. doi:10.1021/jp953538d
15. Mao C, Chamarthy SP, Byrn SR, Pinal R. A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures. Pharm Res. 2006; 23: 2269-2276. doi:10.1007/s11095-006-9071-9 (Pubitemid 44511508)
16. Hancock B, Shamblin S. Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim Acta. 2001; 380: 95-107. doi:10.1016/S0040-6031(01)00663-3 (Pubitemid 33096427)
17. Bohmer R, Ngai KL, Angell CA, Plazek DJ. Nonexponential relaxations in strong and fragile glass formers. J Chem Phys. 1993; 99: 4201-4209. doi:10.1063/1.466117
18. Shamblin SL, Tang X, Chang L, Hancock BC, Pikal MJ. Characterization of the time scales of molecular motion in pharmaceutically important glasses. J Phys Chem B. 1999; 103: 4113-4121. doi:10.1021/jp983964+ (Pubitemid 129702538)
19. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Del Rev. 2001; 48: 27-42. doi:10.1016/S0169-409X(01) 00098-9 (Pubitemid 32454482)
20. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997; 86: 1-12. doi:10.1021/js9601896 (Pubitemid 127489650)
21. Drooge D, Hinrichs W, Visser M, Frijlink H. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm. 2006; 310: 220-229. doi:10.1016/j.ijpharm. 2005.12.007 (Pubitemid 43287987)
22. Royall PG, Craig DCM, Doherty C. Characterisation of moisture uptake effects on the glass transitional behavior of an amorphous drug using modulated temperature DSC. Int J Pharm. 1999; 192: 39-46. doi:10.1016/S0378-5173(99)00270- 7